Literature DB >> 7438562

Characterization of an inhibitor of cell division released in tumour cell cultures.

J Werkmeister, J Zaunders, W McCarthy, P Hersey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7438562      PMCID： PMC1537044     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  12 in total

1.  Analysis of serum blocking factors against leukocyte dependent antibody in melanoma patients.

Authors:  E Murray; S Ruygrok; G W Milton; P Hersey
Journal:  Int J Cancer       Date:  1978-05-15       Impact factor: 7.396

2.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Cancer camouflage.

Authors:  R Graham; J Graham
Journal:  Surg Gynecol Obstet       Date:  1969-04

5.  Approaches for the isolation of biologically functional tumor-associated antigens.

Authors:  R A Reisfeld; G S David; S Ferrone; M A Pellegrino; E C Holmes
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

6.  Restoration of in vitro growth control to malignant cells.

Authors:  G Lipkin; M E Knecht; M Rosenberg
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

7.  Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages.

Authors:  M Nelson; D S Nelson
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

8.  Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance.

Authors:  M C Pike; R Snyderman
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

9.  Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera.

Authors:  P Hersey; M Honeyman; A Edwards; E Adams; W H McCarthy
Journal:  Int J Cancer       Date:  1976-11-15       Impact factor: 7.396

10.  Antiinflammatory effects of murine malignant cells.

Authors:  R M Fauve; B Hevin; H Jacob; J A Gaillard; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205
View more
  11 in total

1.  Abnormalities of T cells isolated from mediastinal lymph nodes and peripheral blood of patients with lung carcinoma: deficit in PHA-induced expression of HLA class II antigens and in autologous mixed lymphocyte reactions.

Authors:  F Indiveri; I Pierri; S Rogna; A Poggi; R Romano; A Tavano; G Ratto; G Motta; S Ferrone
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Anaphylatoxins inhibit C2 production.

Authors:  D Lappin; B Damerau; K Whaley
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

3.  A comparison of the effects of heat-aggregated and chemically cross-linked IgG on monocyte C2 production.

Authors:  K Whaley; D Lappin; A R McPhaden; D W Riches; G P Sandilands
Journal:  Immunology       Date:  1983-07       Impact factor: 7.397

4.  In vivo delayed rejection of tumors and inhibition of delayed-type hypersensitivity by HT-29 human colonic adenocarcinoma cell line.

Authors:  G J Pommier; F L Garrouste; D Bettetini; J M Culouscou; M M Remacle-Bonnet
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

5.  Sister chromatid exchanges in patients with precancerous and cancerous lesions of cervix uteri.

Authors:  V V Murty; A B Mitra; U K Luthra; I P Singh
Journal:  Hum Genet       Date:  1986-01       Impact factor: 4.132

6.  Identification and characterization of a tumor-derived immunosuppressive glycoprotein from murine melanoma K-1735.

Authors:  J B Putnam; J A Roth
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

7.  Inhibition of interleukin-2 production by tumor cell products and by CKS-17, a synthetic retroviral envelope peptide.

Authors:  M Nelson; D Nelson
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

8.  Tumour cell products inhibit both functional and immunoreactive interleukin 2 production by human blood lymphocytes.

Authors:  M Nelson; J A Bremner; D S Nelson
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

9.  Suppression of the generation of lymphokine-activated killer (LAK) cells by serum-free supernatants of in vitro maintained tumour cell lines.

Authors:  P J Guillou; C W Ramsden; S S Somers; P C Sedman
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

10.  5-bp Classical Satellite DNA Loci from Chromosome-1 Instability in Cervical Neoplasia Detected by DNA Breakage Detection/Fluorescence in Situ Hybridization (DBD-FISH).

Authors:  Elva I Cortés-Gutiérrez; Brenda L Ortíz-Hernández; Martha I Dávila-Rodríguez; Ricardo M Cerda-Flores; José Luis Fernández; Carmen López-Fernández; Jaime Gosálvez
Journal:  Int J Mol Sci       Date:  2013-02-19       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.